In melanoma-bearing mice, MSCs treated with kisspeptin‑10 migrated more at 100 nM and less at 500 nM.
In plain wordsIn mice with melanoma, stem cells treated with a lower kisspeptin‑10 dose moved more and with a higher dose moved less.
- Peptide
- Kisspeptin-10
- Outcome
- MixedMSC migration to tumors in vivo
- Study
mousen: not reported in source
C57BL/6 mice bearing melanoma tumors, given kp-10-treated labeled adipose-derived MSCs- Comparator
- Untreated cells
- Outcome group
- Cancer cell invasion and metastasis · Cancer
- Studied dose
- 10-100 or 500 nMAs given in this study (mouse).
Source sentences
We have found that kp-10 increased the MSCs migration at 100 nM, while it decreased the MSCs migration at 500 nM, both in vitro and in vivo
2 context sentences(design, population, supporting numbers)
We compared the directional migration of MSCs treated with 10-100 or 500 nM kp-10 for 24 hours and no treated cells using an in vitro transmembrane migration assay.
In addition, Chloromethylbenzamido Dialkylacarbocyanine (CM-Dil) labeled adipose-derived mesenchymal stem cells treated with 10-100 or 500 nM kp-10 and no treated cells were transfused via the tail vein to the melanoma tumor bearing C57BL/6 mice.